Physician profile
Georgia Scott
NPI 1184648289
$324.86
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $84.94 · 2021: $22.44.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $107.88 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $39.50 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $33.22 | 2019 | |
| Pfizer INC. | $26.64 | 2019 | |
| Novartis Pharmaceuticals Corporation | $26.16 | 2019 | |
| Abbvie INC. | $22.44 | 2021 | |
| Boston Scientific Corporation | $16.33 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.85 | 2020 | |
| Merck Sharp & Dohme LLC | $13.91 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.74 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.19 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Georgia Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.